Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s (SHSE:600196) dividend is being reduced from last year’s payment covering the same period to CN¥0.27 on the 6th of August. Based on this payment, the dividend yield will be 1.1%, which is lower than the average for the industry.
Check out our latest analysis for Shanghai Fosun Pharmaceutical (Group)
Shanghai Fosun Pharmaceutical (Group)’s Earnings Easily Cover The Distributions
While yield is important, another factor to consider about a company’s dividend is whether the current payout levels are feasible. Shanghai Fosun Pharmaceutical (Group) is quite easily earning enough to cover the dividend, however it is being let down by weak cash flows. With the company not bringing in any cash, paying out to shareholders is bound to become difficult at some point.
The next year is set to see EPS grow by 28.1%. If the dividend continues along recent trends, we estimate…
